Stock listing

Intellia Therapeutics, Inc. (38I) Stock Price, News, Filings & Events

Selected listing: 38I · BX · CHF · CH

This page tracks Intellia Therapeutics, Inc.'s 38I:BX listing on BX in CHF for CH, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 38I:BX. 38I:BX is the selected stock listing for investors researching Intellia Therapeutics, Inc.; the company-level investor brief is shared across the issuer while this page keeps ticker, exchange, currency, and canonical URL signals specific to 38I:BX. Intellia Therapeutics, Inc. is a public biotechnology company listed on 6ix the American stock market. The company focuses on developing innovative gene-editing therapies. As of now, Intellia has a market capitalization of approximately $2. 19 billion.

website38I:BXCHFCHSEO content: aiUpdated June 26, 2026/stock/bx-38i/intellia-therapeutics-inc/l-ghiwlgu4ov
Intellia Therapeutics, Inc. logo
Ticker
38I:BX
Asset type
Stock
Market cap
$2.33B
Sector
Health Technology
Industry
Biotechnology
Exchange
BX
Currency
CHF

Intellia Therapeutics, Inc. 38I:BX stock context

This page tracks Intellia Therapeutics, Inc.'s 38I:BX listing on BX in CHF for CH, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 38I:BX. 38I:BX is the selected stock listing for investors researching Intellia Therapeutics, Inc.; the company-level investor brief is shared across the issuer while this page keeps ticker, exchange, currency, and canonical URL signals specific to 38I:BX. Intellia Therapeutics, Inc. is a public biotechnology company listed on 6ix the American stock market. The company focuses on developing innovative gene-editing therapies. As of now, Intellia has a market capitalization of approximately $2. 19 billion.

Research Intellia Therapeutics, Inc.

Alternate listings